Detection of Biofilm in Wounds as an Early Indicator for Risk for Tissue Infection and Wound Chronicity

Annals of Plastic Surgery

Volumn 76, Issue 1, 2016, Pages 127-131

  Vyas, Krishna S ^a   Wong, Lesley K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

biofilm; biofilm detection; biofilm matrix; chronic wound

Indexed keywords

ANTIINFECTIVE AGENT; CULTURE MEDIUM;

BACTERIAL COUNT; BACTERIAL INFECTIONS; BIOFILM; CHRONIC DISEASE; CULTURE MEDIUM; DRUG EFFECTS; EARLY DIAGNOSIS; ESCHERICHIA COLI; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; MICROBIOLOGY; PREDICTIVE VALUE; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; WOUND INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOFILMS; CHRONIC DISEASE; COLONY COUNT, MICROBIAL; CULTURE MEDIA; EARLY DIAGNOSIS; ESCHERICHIA COLI; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; WOUND INFECTION;

EID: 84951866782     PISSN: 01487043     EISSN: 15363708     Source Type: Journal    
DOI: 10.1097/SAP.0000000000000440     Document Type: Review

References (69)

1. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: A unifying hypothesis. Plast Reconstr Surg. 2006;117: 35S-41S.
2. Wolcott R, Costerton JW, Raoult D, et al. The polymicrobial nature of biofilm infection. Clin Microbiol Infect. 2013;19:107-112.
3. Kirketerp-Moller K, Jensen PO, Fazli M, et al. Distribution, organization, and ecology of bacteria in chronic wounds. J ClinMicrobiol. 2008;46:2717-2722.
4. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284:1318-1322.
5. Roche ED, Renick PJ, Tetens SP, et al. Increasing the presence of biofilm and healing delay in a porcine model of MRSA-infected wounds. Wound Repair Regen. 2012;20:537-543.
6. James GA, Swogger E ,Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16:37-44.
7. Lappin-Scott HM, Bass C. Biofilm formation: Attachment, growth, and detachment of microbes from surfaces. Am J Infect Control. 2001;29:250-251.
8. O'Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54:49-79.
9. Sauer K, Camper AK, Ehrlich GD, et al. Pseudomonas aeruginosa displays multiple phenotypes during development as a biofilm. J Bacteriol. 2002;184: 1140-1154.
10. Wolcott RD, Rhoads DD, Dowd SE. Biofilms and chronic wound inflammation. J Wound Care. 2008;17:333-341.
11. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science. 2006;311:1113-1116.
12. Nadell CD, Xavier JB, Levin SA, et al. The evolution of quorum sensing in bacterial biofilms. PLoS Biol. 2008;6:e14.
13. Dunne WMJr. Bacterial adhesion: Seen any good biofilms lately Clin Microbiol Rev. 2002;15:155-166.
14. Rhoads DD, Wolcott RD, Percival SL. Biofilms in wounds: Management strategies. J Wound Care. 2008;17:502-508.
15. Sutherland I. Biofilm exopolysaccharides: A strong and sticky framework. Microbiology. 2001;147:3-9.
16. Ryder C, Byrd M, Wozniak DJ. Role of polysaccharides in Pseudomonas aeruginosa biofilm development. Curr Opin Microbiol. 2007;10:644-648.
17. Leid JG, Willson CJ, Shirtliff ME, et al. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma-mediated macrophage killing. J Immunol. 2005;175:7512-7518.
18. Hall-Stoodley L, Stoodley P, Kathju S, et al. Towards diagnostic guidelines for biofilm-associated infections. FEMS Immunol Med Microbiol. 2012;65: 127-145.
19. Bjarnsholt T, Alhede M, Alhede M, et al. The in vivo biofilm. Trends Microbiol. 2013;21:466-474.
20. Jensen PO, Bjarnsholt T, Phipps R, et al. Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa. Microbiology. 2007;153:1329-1338.
21. Walker TS, Tomlin KL, Worthen GS, et al. Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils. Infect Immunity. 2005;73: 3693-3701.
22. Alhede M, Bjarnsholt T, Givskov M, et al. Pseudomonas aeruginosa biofilms: Mechanisms of immune evasion. Adv Appl Microbiol. 2014;86:1-40.
23. Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280:295-298.
24. Spoering AL, Gilmore MS. Quorum sensing and DNA release in bacterial biofilms. Curr Opin Microbiol. 2006;9:133-137.
25. Patriquin GM, Banin E, Gilmour C, et al. Influence of quorum sensing and iron on twitching motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol. 2008;190:662-671.
26. Stewart PS. Diffusion in biofilms. J Bacteriol. 2003;185:1485-1491.
27. Stewart PS, Franklin MJ. Physiological heterogeneity in biofilms. Nat Rev Microbiol. 2008;6:199-210.
28. Walters MC 3rd, Roe F, Bugnicourt A, et al. Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin. Antimicrob Agents Chemother. 2003;47:317-323.
29. Masyuko RN, Lanni EJ, Driscoll CM, et al. Spatial organization of Pseudomonas aeruginosa biofilms probed by combined matrix-assisted laser desorption ionization mass spectrometry and confocal Raman microscopy. Analyst. 2014;139: 5700-5708.
30. Davey ME, Caiazza NC, O'Toole GA. Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol. 2003;185: 1027-1036.
31. Hengge-Aronis R Regulation of gene expression during entry into stationary phase. In: Neidhardt FC, et al. eds. Escherichia coli and Salmonella Cellular and Molecular Biology. Washington, DC, ASM Press;1996.
32. Percival SL, Hill KE, Williams DW, et al. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 2012;20:647-657.
33. Parsek MR, Singh PK. Bacterial biofilms: An emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677-701.
34. Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11:1034-1043.
35. Hoiby N, Bjarnsholt T, Givskov M, et al. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35:322-332.
36. Yang Q, Phillips PL, Sampson EM, et al. Development of a novel ex vivo porcine skin explantmodel for the assessment of mature bacterial biofilms. Wound Repair Regen. 2013;21:704-714.
37. Mendes JJ, Leandro CI, Bonaparte DP, et al. A rat model of diabetic wound infection for the evaluation of topical antimicrobial therapies. Comp Med. 2012;62:37-48.
38. Kim J, Pitts B, Stewart PS, et al. Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm. Antimicrob Agents Chemother. 2008; 52:1446-1453.
39. Wolcott RD, Dowd SE. A rapid molecular method for characterising bacterial bioburden in chronic wounds. J Wound Care. 2008;17:513-516.
40. Rhoads DD, Cox SB, Rees EJ, et al. Clinical identification of bacteria in human chronic wound infections: Culturing vs. 16S ribosomal DNA sequencing. BMC Infect Dis. 2012;12:321.
41. Trampuz A, Piper KE, Jacobson MJ, et al. Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl JMed. 2007;357:654-663.
42. Thomsen TR, Aasholm MS, Rudkjobing VB, et al. The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods. Wound Repair Regen. 2010;18:38-49.
43. Fazli M, Bjarnsholt T, Kirketerp-Moller K, et al. Nonrandom distribution of Pseudomonas aeruginosa and Staphylococcus aureus in chronic wounds. J Clin Microbiol. 2009;47:4084-4089.
44. Drago L, Lombardi A, Vecchi ED, et al. Real-time PCR assay for rapid detection of Bacillus anthracis spores in clinical samples. J ClinMicrobiol. 2002;40:4399.
45. Rhoads DD, Wolcott RD, Sun Y, et al. Comparison of culture and molecular identification of bacteria in chronic wounds. Int J Mol Sci. 2012;13:2535-2550.
46. Sampath R, Hall TA, Massire C, et al. Rapid identification of emerging infectious agents using PCR and electrospray ionization mass spectrometry. Ann N Y Acad Sci. 2007;1102:109-120.
47. Pathak S, Awuh JA, Leversen NA, et al. Countingmycobacteria in infected human cells and mouse tissue: A comparison between qPCR and CFU. PloS One. 2012;7: E34931.
48. Pisz JM, Lawrence JR, Schafer AN, et al. Differentiation of genes extracted from non-viable versus viable micro-organisms in environmental samples using ethidium monoazide bromide. J Microbiol Methods. 2007;71:312-318.
49. Post JC, Aul JJ, White GJ, et al. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am J Otolaryngol. 1996;17:106-111.
50. Brady RA, Leid JG, Camper AK, et al. Identification of Staphylococcus aureus proteins recognized by the antibody-mediated immune response to a biofilm infection. Infect Immun. 2006;74:3415-3426.
51. Beloin C, Ghigo JM. Finding gene-expression patterns in bacterial biofilms. Trends Microbiol. 2005;13:16-19.
52. Cury JA, Seils J, Koo H. Isolation and purification of total RNA from Streptococcus mutans in suspension cultures and biofilms. Braz Oral Res. 2008;22:216-222.
53. Cramton SE, Gerke C, Schnell NF, et al. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 1999;67:5427-5433.
54. Sontakke S, Cadenas MB, Maggi RG, et al. Use of broad range16S rDNA PCR in clinical microbiology. J Microbiol Methods. 2009;76:217-225.
55. Costerton JW, Post JC, Ehrlich GD, et al. New methods for the detection of orthopedic and other biofilm infections. FEMS Immunol Med Microbiol. 2011;61: 133-140.
56. Sampath R. Advanced techniques for detection and identification of viral contaminants using the Ibis PLEX-ID universal biosensor. PDA J Pharm Sci Technol. 2011;65:690.
57. Harrison-Balestra C, Cazzaniga AL, Davis SC, et al. A wound-isolated Pseudomonas aeruginosa grows a biofilm in vitro within 10 hours and is visualized by light microscopy. Dermatol Surg. 2003;29:631-635.
58. Lawrence JR, Korber DR, Hoyle BD, et al. Optical sectioning of microbial biofilms. J Bacteriol. 1991;173:6558-6567.
59. Davis SC, Ricotti C, Cazzaniga A, et al. Microscopic and physiologic evidence for biofilm-associated wound colonization in vivo. Wound Repair Regen. 2008; 16:23-29.
60. Anastasiadis P, Mojica KD, Allen JS, et al. Detection and quantification of bacterial biofilms combining high-frequency acoustic microscopy and targeted lipid microparticles. J Nanobiotechnol. 2014;12:24.
61. Brauer HA, Makowski L, Hoadley KA, et al. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res. 2013;19:571-585.
62. Zhang B, Powers R. Analysis of bacterial biofilms using NMR-based metabolomics. Future Medicinal Chemistry. 2012;4:1273-1306.
63. Gjersing EL, Herberg JL, Horn J, et al. NMR metabolomics of planktonic and biofilm modes of growth in Pseudomonas aeruginosa. Anal Chem. 2007;79: 8037-8045.
64. Wolcott RD, Rumbaugh KP, James G, et al. Biofilm maturity studies indicate sharp debridement opens a time-dependent therapeutic window. J Wound Care. 2010;19:320-328.
65. Lewandowski Z, Beyenal H. Fundamentals of Biofilm Research. 2nd ed. Boca Raton, FL: CRC Press, 2014: 74-78.
66. Ammons MC, Copie V. Mini-review: Lactoferrin: A bioinspired, anti-biofilm therapeutic. Biofouling. 2013;29:443-455.
67. Kaplan JB, Ragunath C, Velliyagounder K, et al. Enzymatic detachment of Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2004; 48:2633-2636.
68. Xavier JB, Picioreanu C, Rani SA, et al. Biofilm-control strategies based on enzymic disruption of the extracellular polymeric substance matrix-a modelling study. Microbiology. 2005;151:3817-3832.
69. Kaplan JB. Biofilm dispersal: Mechanisms, clinical implications, and potential therapeutic uses. J Dent Res. 2010;89:205-218.